Bionexus Gene La (BGLC) Revenue by Year
Bionexus Gene La generated $7.4M in revenue in fiscal year 2025. This represents a decrease of 21.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $3.1M in revenue. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Bionexus Gene La has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BGLC Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
BGLC Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Bionexus Gene La financials
Frequently Asked Questions
What was Bionexus Gene La's revenue in fiscal year 2025?
Bionexus Gene La generated $7.4M in revenue in fiscal year 2025.
How fast is Bionexus Gene La's revenue growing?
Bionexus Gene La (BGLC) revenue fell by 21.9% year over year, from $9.5M to $7.4M in fiscal year 2025.
What is Bionexus Gene La's revenue over the last twelve months?
Bionexus Gene La (BGLC) reported $3.1M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Bionexus Gene La's revenue changed over the years?
Across the 8 fiscal years this page covers, Bionexus Gene La (BGLC) revenue went from $212K in fiscal year 2018 to $7.4M in fiscal year 2025.
What was Bionexus Gene La's revenue in the most recent quarter?
Bionexus Gene La (BGLC) reported $76K in revenue in Q2 2026. This represents a decrease of 96.6% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Bionexus Gene La (BGLC) reported on that line in every period on record.